Meld Valuation / Venture NAV Tracker
FundsCompaniesMethodology
meldvaluation.com ↗

Venture NAV Tracker / Private company

Altimmune, Inc.

Drug Discovery & Development
Headquarters—
Founded—
Last known round—
Reported valuation—

Cross-fund comparison

Current disclosed marks

One latest disclosed debt mark per fund.

FundSecurity type / basisPrincipalFair valueFV / principalRateMaturityMark age vs roundNon-accrual
HTGCHercules Capital, Inc.senior secured loanFair Value — Senior Secured$17.5MMar 31, 2026 · source ↗$17.4MMar 31, 2026 · source ↗99.2%Mar 31, 2026 · source ↗Prime + 2.45 %, Floor rate 9.70 %, 6.25 % Exit FeeMar 31, 2026 · source ↗Jun 1, 2029Mar 31, 2026 · source ↗—Mar 31, 2026 · source ↗NoMar 31, 2026 · source ↗

Historical marks

Reported fair value by fund

Each bar is a disclosed position-quarter.

$17.4MHTGCMar 31, 2026 · source ↗
Figures are compiled from public filings.Read methodologyMELD Valuation